Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review


April 16, 2013
25 Pages - SKU: GBDT5024139
License type:


Summary

Laboratoires Pierre Fabre SA (Pierre Fabre) is a pharmaceutical laboratory. It provides a wide range of ethical products, health products and dermo-cosmetic products. The company sells and markets its products through brands such as Derma, Galenic Klorane, Avene, Ducray and Rene Furterer. The company's research and development activities focus on areas such as cancerology, urology, cardiology, psychiatry, phlebology, pneumology, infectiology, gynaecology and rhumatology. Pierre Fabre is headquartered in Castres Cedex, France.

The key business strategies of the company include focusing on developing new innovative products and solutions for the treatment of various life threatening diseases. It also aims to maintain its existing partnerships and enter into new collaborative agreements to augment its research and development efforts and increase the know-how of research centers for development and services. This is evident from the recent partnership and collaboration agreements it signed with Merz Pharmaceuticals for the marketing of injectable Glytone; and Adventrx for the manufacture of Active Anx-188.

GlobalData’s Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.



More Pharmaceuticals Company reports by GlobalData

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013 by GlobalData
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013SummaryGlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 ...
PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry by GlobalData
PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical IndustrySummaryPharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform ...
Kuros Biosurgery AG - Product Pipeline Analysis, 2013 Update by GlobalData
SummaryKuros Biosurgery AG (Kuros) is a medical technology company.The company develops injectable biomaterial products for the trauma and wound care markets. It was formed as ...
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2013 Update by GlobalData
SummaryOPKO Health, Inc. (OPKO), formerly eXegenics, Inc., is a US-based pharmaceutical and health care service provide. It operates in the diagnostics and pharmaceutical markets. The ...
See all reports like this >>